drugset / Trial / NCT06720259
Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura
RandomizedParallel-groupTriple-blindTreatment
Summary
This study aims to provide evidence on the efficacy, safety and acceptability of the new, chewable formulation of oxantel pamoate administered as a single dose or multiple doses, compared to mebendazole in children infected with T. trichiura. This study will involve children aged 2-12 years, since an infection with T. trichiura occurs often in children.
Timeline
- Start
- 2025-04-16
- Primary completion
- 2025-05-28
- Completion
- 2025-05-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mebendazole | Small molecule | 500 mg | Oral |
| Subject | Oxantel Pamoate | Unknown | 20 mg/kg | Oral |